Epidemiology of heart failure in diabetes: a disease in disguise Anna G. HoekElisa Dal CantoJoline W. J. Beulens Review Open access 09 February 2024 Pages: 574 - 601
Remission of type 2 diabetes: always more questions, but enough answers for action Amy RothbergMichael LeanBlandine Laferrère Review Open access 08 January 2024 Pages: 602 - 610
Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes Karoliina TuomelaMegan K. Levings Review 18 January 2024 Pages: 611 - 622
A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes Mengqi GuoHan GuoShufa Li Article 13 February 2024 Pages: 623 - 640
QRS-T angle: is it a specific parameter associated with sudden cardiac death in type 2 diabetes? Results from the SURDIAGENE and the Mini-Finland prospective cohorts Rodrigue GarciaLinda C. Schröderon behalf of the SURDIAGENE and the Mini-Finland study groups Article 24 January 2024 Pages: 641 - 649
Cost–utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium Margaretha M. VisserAstrid Van MuylderNick Verhaeghe Article 18 January 2024 Pages: 650 - 662
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia Hamzah AlzubaidiVitor H. OliveiraJonathan E. Shaw Short Communication Open access 12 January 2024 Pages: 663 - 669
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes Sandra HummelSarah Rosenbergerfor the GPPAD and POInT Study Group Article Open access 12 January 2024 Pages: 670 - 678
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study John SamuelssonRebecka BertilssonKarin Åkesson Article Open access 22 January 2024 Pages: 679 - 689
Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study Nikki C. C. WerkmanGema García-SáezCoen D. A. Stehouwer Article Open access 11 January 2024 Pages: 690 - 702
Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits Jianxin ZhenYuqin GuSiyang Liu Article Open access 19 February 2024 Pages: 703 - 713
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children Sara BruzzanitiErica PiemonteMario Galgani Article Open access 12 January 2024 Pages: 714 - 723
Skeletal muscle TET3 promotes insulin resistance through destabilisation of PGC-1α Beibei LiuDi XieYingqun Huang Article Open access 13 January 2024 Pages: 724 - 737
Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns Mingwei ShaoDuo ChenGuijun Qin Article 18 January 2024 Pages: 738 - 754
Morning exercise as fasted-state activity. Reply to Chacko E [letter] Caiwei TianChirag J. Patel Letter 25 January 2024 Pages: 757 - 757
Correction to: Dose–response effects on HbA1c and bodyweight reduction of survodutide, a dual glucagon/GLP-1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial Matthias BlüherJulio RosenstockAnita M. Hennige Correction Open access 13 February 2024 Pages: 758 - 758
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial Zatollah AsemiMaryam KaramaliAhmad Esmaillzadeh Editorial Expression of Concern 30 January 2024 Pages: 759 - 760
